litlas
ログインアカウント作成

Hys Ngan

1978–2025 年に発表

129
論文数
19,782
被引用数
80
h 指数
127
i10 指数

被引用数

Hys Ngan の年別被引用数1979 年: 被引用 2 件1980 年: 被引用 1 件1984 年: 被引用 2 件1991 年: 被引用 2 件1992 年: 被引用 3 件1993 年: 被引用 2 件1994 年: 被引用 3 件1995 年: 被引用 3 件1996 年: 被引用 3 件1997 年: 被引用 8 件1998 年: 被引用 5 件1999 年: 被引用 4 件2000 年: 被引用 13 件2001 年: 被引用 20 件2002 年: 被引用 36 件2003 年: 被引用 57 件2004 年: 被引用 68 件2005 年: 被引用 66 件2006 年: 被引用 89 件2007 年: 被引用 84 件2008 年: 被引用 102 件2009 年: 被引用 146 件2010 年: 被引用 132 件2011 年: 被引用 157 件2012 年: 被引用 191 件2013 年: 被引用 142 件2014 年: 被引用 142 件2015 年: 被引用 133 件2016 年: 被引用 107 件2017 年: 被引用 111 件2018 年: 被引用 99 件2019 年: 被引用 484 件2020 年: 被引用 578 件2021 年: 被引用 536 件2022 年: 被引用 419 件2023 年: 被引用 309 件2024 年: 被引用 567 件2025 年: 被引用 264 件2026 年: 被引用 6 件1981〜1983 年は被引用が無いため表示していません1985〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 1,426 件、この内訳の 20.6%アメリカ合衆国: 引用元論文 1,328 件、この内訳の 19.2%イギリス: 引用元論文 352 件、この内訳の 5.1%イタリア: 引用元論文 342 件、この内訳の 4.9%日本: 引用元論文 252 件、この内訳の 3.6%ドイツ: 引用元論文 221 件、この内訳の 3.2%インド: 引用元論文 185 件、この内訳の 2.7%カナダ: 引用元論文 182 件、この内訳の 2.6%スペイン: 引用元論文 182 件、この内訳の 2.6%香港: 引用元論文 180 件、この内訳の 2.6%韓国: 引用元論文 179 件、この内訳の 2.6%フランス: 引用元論文 176 件、この内訳の 2.6%
0%20.6%その他 27.7%

機関

分野

  • Medicine60.7%
  • Biochemistry, Genetics and Molecular Biology32.3%
  • Immunology and Microbiology2.9%
  • Neuroscience0.5%
  • Engineering0.5%
  • Computer Science0.4%
  • その他2.7%

トピック

  • Hepatocellular Carcinoma Treatment and Prognosis5.4%
  • Endometrial and Cervical Cancer Treatments5.2%
  • Ovarian cancer diagnosis and treatment4.6%
  • MicroRNA in disease regulation2.4%
  • Cervical Cancer and HPV Research2.4%
  • Cancer, Hypoxia, and Metabolism2.3%
  • その他77.7%

共著者

全論文

検索で開く
  1. SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells

    著者: Xuan Yang, Huogang Wang, Mingo M. H. Yung, Fushun Chen, Wai-Sun Chan, Yau-Sang Chan, Stephen Kwok‐Wing Tsui, Hys Ngan, Karen K. L. Chan, David W. Chan - Theranostics 2022 被引用: 251

  2. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression

    著者: Huogang Wang, Mingo M. H. Yung, Hys Ngan, Karen K. L. Chan, David W. Chan - International Journal of Molecular Sciences 2021 被引用: 246

  3. Molecular Biomarkers for the Early Detection of Ovarian Cancer

    著者: Ruiqian Zhang, Michelle K.Y. Siu, Hys Ngan, Karen K. L. Chan - International Journal of Molecular Sciences 2022 被引用: 261

  4. Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis

    著者: Yulan Mo, Leanne Lee Leung, Celia S. L. Mak, Xueyu Wang, Wai-Sun Chan, Lynn Hui, Hermit Wai‐Man Tang, Michelle K.Y. Siu, Rakesh Sharma, Dakang Xu, Stephen Kwok‐Wing Tsui, Hys Ngan, Mingo M. H. Yung, Karen K. L. Chan, David W. Chan - Molecular Cancer 2023 被引用: 94

  5. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

    著者: Chung‐Mau Lo, Hys Ngan, Wai‐Kuen Tso, Chi‐Leung Liu, Chi‐Ming Lam, Ronnie Tung‐Ping Poon, Sheung-Tat Fan, John Wong - Hepatology 2002 被引用: 2,627

  6. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis

    著者: David W. Chan, Mingo M. H. Yung, Yau-Sang Chan, Xuan Yang, Huijuan Yang, Dakang Xu, Jinbiao Zhan, Karen K. L. Chan, Tzi‐Bun Ng, Hys Ngan - Pharmacological Research 2020 被引用: 125

  7. Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface

    著者: Maggie K. S. Tang, Patrick Ying‐Kit Yue, Philip P.C. Ip, Rui Huang, Hung-Cheng Lai, Any Cheung, Ka Yu Tse, Hys Ngan, Alice S.T. Wong - Nature Communications 2018 被引用: 233

  8. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades

    著者: Michelle K.Y. Siu, Yuxin Jiang, Jingjing Wang, Thomas Leung, Chae Young Han, Benjamin K. Tsang, Any Cheung, Hys Ngan, Karen K. L. Chan - Cancers 2019 被引用: 138

  9. Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer

    著者: Monika Janda, Val Gebski, Lucy Davies, Peta Forder, Alison H. Brand, Russell Hogg, Thomas W. Jobling, Russell Land, Tom Manolitsas, Marcelo Nascimento, Deborah Neesham, James Nicklin, Martin K. Oehler, Geoff Otton, Lewis Perrin, Stuart Salfinger, Ian Hammond, Yee Leung, Peter Sykes, Hys Ngan, Andrea Garrett, Michael Laney, Tong Yow Ng, Kar‐Fai Tam, Karen K. L. Chan, C. David Wrede, Selvan Pather, Bryony Simcock, Rhonda Farrell, Gregory Robertson, Graeme Walker, Nigel R Armfield, Nick Graves, Anthony J. McCartney, Andreas Obermair - JAMA 2017 被引用: 418

  10. Diagnosis and Management of Gestational Trophoblastic Disease: 2021 Update

    著者: Hys Ngan, Michael J. Seckl, Ross S. Berkowitz, Yang Xiang, François Golfier, Paradan K. Sekharan, John R. Lurain, Leon F.A.G. Massuger - International Journal of Gynecology & Obstetrics 2021 被引用: 287

  11. Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer

    著者: Karen K. L. Chan, Michelle K.Y. Siu, Yuxin Jiang, Jingjing Wang, Thomas Leung, Hys Ngan - Cancer Cell International 2018 被引用: 120

  12. Paradoxical Impact of Two Folate Receptors, FRα and RFC, in Ovarian Cancer: Effect on Cell Proliferation, Invasion and Clinical Outcome

    著者: Michelle K.Y. Siu, Daniel S. Kong, Hoi Yan Chan, Esther S.Y. Wong, Philip P.C. Ip, LiLi Jiang, Hys Ngan, Xiao-Feng Le, Any Cheung - PLoS ONE 2012 被引用: 103

  13. Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline

    著者: Linus Chuang, Sarah Temin, Rolando Camacho, Alfonso Dueñas‐González, Sarah Feldman, Murat Gültekin, Vandana Gupta, Susan Horton, Graciela Jacob, Elizabeth Kidd, Kennedy Lishimpi, Carolyn Nakisige, Joo‐Hyun Nam, Hys Ngan, William Small, Gillian Thomas, Jonathan S. Berek - Journal of Global Oncology 2016 被引用: 200

  14. A Combination of Glutaminase Inhibitor 968 and PD-L1 Blockade Boosts the Immune Response against Ovarian Cancer

    著者: Jingjing Wang, Michelle Kwan-Yee Siu, Yuxin Jiang, Thomas Leung, David W. Chan, Huogang Wang, Hys Ngan, Karen K. L. Chan - Biomolecules 2021 被引用: 39

  15. Carcinoma of the Corpus Uteri

    著者: WT CREASMAN, Franco Odicino, Patrick Maisonneuve, MA QUINN, U. Beller, JL BENEDET, A P Heintz, Hys Ngan, Sërgio Pecorelli - International Journal of Gynecology & Obstetrics 2006 被引用: 979

  16. Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells

    著者: Rain R. Chen, Mingo M. H. Yung, Xuan Yang, Shijie Zhan, Leanne Lee Leung, Rachel R. Liang, Thomas H. Y. Leung, Huijuan Yang, Dakang Xu, Rakesh Sharma, Karen K. L. Chan, Siew‐Fei Ngu, Hys Ngan, David W. Chan - Communications Biology 2019 被引用: 105

  17. PDK1 promotes ovarian cancer metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via α5β1 integrin and JNK/IL-8 signaling

    著者: Michelle K.Y. Siu, Yuxin Jiang, Jingjing Wang, Thomas Leung, Siew‐Fei Ngu, Any Cheung, Hys Ngan, Karen K. L. Chan - Oncogenesis 2020 被引用: 75

  18. RETRACTED ARTICLE: miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer

    著者: Jing Sun, Xin Cai, Mingo M. H. Yung, Wei Zhou, Jing Li, Yi Zhang, Zhuqing Li, Stephanie S. Liu, Any Cheung, Hys Ngan, Yiliang Li, Zhijun Dai, Kai Yan, Alexandros Tzatsos, Weiqun Peng, David W. Chan, Wenge Zhu - Oncogene 2018 被引用: 142

  19. Ascites-derived ALDH+CD44+ tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3/AKT/NF-κB/IL-8 signalling in ovarian cancer

    著者: Yuxin Jiang, Michelle Kwan-Yee Siu, Jingjing Wang, Xue-Tang Mo, Thomas Leung, David W. Chan, Any Cheung, Hys Ngan, Karen K. L. Chan - British Journal of Cancer 2020 被引用: 52

  20. Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers

    著者: David W. Chan, Wai-Yip Lam, Fushun Chen, Mingo M. H. Yung, Yau-Sang Chan, Wai-Sun Chan, Fangfang He, Stephanie S. Liu, Karen K. L. Chan, Benjamin Li, Hys Ngan - Clinical Epigenetics 2021 被引用: 44

  21. Aberrant upregulation of PDK1 in ovarian cancer cells impairs CD8+ T cell function and survival through elevation of PD-L1

    著者: Jingjing Wang, Michelle K.Y. Siu, Yuxin Jiang, Thomas Leung, David W. Chan, Ranran Cheng, Any Cheung, Hys Ngan, Karen K. L. Chan - OncoImmunology 2019 被引用: 38

  22. Update on the diagnosis and management of gestational trophoblastic disease

    著者: Hys Ngan, Michael J. Seckl, Ross S. Berkowitz, Yang Xiang, François Golfier, Paradan K. Sekharan, John R. Lurain, Leon F.A.G. Massuger - International Journal of Gynecology & Obstetrics 2018 被引用: 447

  23. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

    著者: Ignace Vergote, Giovanni Scambia, David M. O’Malley, Ben Van Calster, Sang‐Yoon Park, Josep M. del Campo, Werner Meier, Aristotelis Bamias, Nicoletta Colombo, Robert M. Wenham, Al Covens, Christian Marth, Mansoor Raza Mirza, Judith R. Kroep, Haijun Ma, Cheryl A. Pickett, Bradley J. Monk, Ignace Vergote, Giovanni Scambia, Sangyoon Park, Yong Sang Song, Yulia Makarova, Joshua Trinidad, Hys Ngan, Aristotelis Bamias, Gerasimos Aravantinos, Joo‐Hyun Nam, Vera Gorbunova, Л. И. Крикунова, Duk‐Soo Bae, Jóse Ángel Arranz Arija, Mansoor Raza Mirza, Claudio Zamagni, Christos N. Papandreou, Francesco Raspagliesi, Alla Lisyanskaya, Ana Oaknin Benzaquen, Germana Tognon, Eugenia Ortega, Antonio Casado Herraez, Joseph Buscema, Andrew Green, Robert A. Burger, Dina Sakaeva, Andres Redondo Sanchez, Sharad Ghamande, Laurel A. King, Edgar Petru, Ulla Peen, Satoshi Takeuchi, Kimio Ushijima, Antonio González-Martı́n, Scott Kamelle, Michael E. Carney, Christian Marth, Frédéric Forget, J. Bentley, Jalid Sehouli, Nicoletta Colombo, Paolo Zola, Hidenori Kato, Natalya Fadeeva, Evgeny Gotovkin, Vladimir Vladimirov, Margarita Romeo Marin, Eva Guerra Alía, Mark S. Shahin, Snehalkumar M Bhoola, Krishnansu S. Tewari, Daniel M. Anderson, Brigitte Honhon, J. Pelgrims, Amit M. Oza, Jesús García-Donás Jiménez, Vincent Hansen, David M. O’Malley, Ivor Benjamin, Vincent Renard, Heidi Van den Bulck, Werner Meier, Claudia Haenle, G. Koumakis, Harushige Yokota, В.М. Попов, William E. Bradley, Robert M. Wenham, Robert H. Reid, Donna McNamara, Richard D. Friedman, Joyce N. Barlin, Nicola M. Spirtos, Julia Chapman, P. Sevelda, Manon Huizing, C. Lamot, Frédéric Goffin, Lionel D. Hondt, Allan Covens, Silvana Spadafora, Beate Rautenberg ほか 237 名 - The Lancet Oncology 2019 被引用: 86

  24. Carcinoma of the Ovary

    著者: APM Heintz, Franco Odicino, Patrick Maisonneuve, MA QUINN, JL BENEDET, WT CREASMAN, Hys Ngan, S. Pecorelli, U. Beller - International Journal of Gynecology & Obstetrics 2006 被引用: 1,284